{
  "trade_date": "2026-04-15",
  "tickers": [
    "RVMD",
    "CAR",
    "ORCL",
    "HOLX",
    "EXAS",
    "PAYC",
    "CINF",
    "NI",
    "CMCSA",
    "AVB",
    "CTRA",
    "EA",
    "EQR",
    "DTST",
    "KOPN",
    "CCEL",
    "ANGO",
    "GIPR",
    "PXED",
    "BEEM",
    "RPM",
    "ARAI",
    "NEOG",
    "FAT",
    "CARM",
    "GRDX",
    "MTB",
    "OLOX",
    "BPTH",
    "HOMB",
    "TRAW",
    "CLSD",
    "LFLY",
    "INTU",
    "COIN",
    "NVDA",
    "IRDM",
    "AME",
    "CTAS",
    "ETN",
    "CAMP",
    "JBL",
    "DIOD",
    "SMC",
    "LW",
    "SG",
    "HTO",
    "RPAY",
    "BETR",
    "GF",
    "MNR",
    "ACET",
    "CHPT",
    "WKSP",
    "CNXC",
    "SVBL",
    "FROPX",
    "FRBBX",
    "SWZ",
    "ABX",
    "ACHC",
    "AI",
    "ARCT",
    "ANAB",
    "RIME",
    "AR"
  ],
  "filtered_tickers": [
    "RPM",
    "ABX",
    "ACHC",
    "ANAB",
    "CTRA",
    "AME",
    "CTAS",
    "ETN",
    "AR",
    "EA",
    "EQR"
  ],
  "final_ranking": [
    {
      "rank": 1,
      "ticker": "ACHC",
      "company_name": "Acadia Healthcare Company, Inc.",
      "current_price": 26.610000610351562,
      "strategy_match": "short_squeeze",
      "final_score": 85,
      "confidence": 8,
      "risk_level": "moderate",
      "reason": "This is a prime short squeeze setup featuring an extreme 42.1% short interest and 6.5 days to cover, a strategy boasting a historical 60.0% 7-day win rate. The stock is exhibiting momentum acceleration, breaking into a strong uptrend well above its 50-day SMA of $21.24 with rising on-balance volume. Options market sentiment strongly corroborates the technical breakout, marked by an unusually low 0.31 put/call volume ratio indicating heavy call accumulation. The primary risk is a broader market selloff or premature profit-taking ahead of their upcoming April 29th earnings report.",
      "description": "Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico."
    },
    {
      "rank": 2,
      "ticker": "ANAB",
      "company_name": "AnaptysBio, Inc.",
      "current_price": 67.88999938964844,
      "strategy_match": "short_squeeze",
      "final_score": 82,
      "confidence": 8,
      "risk_level": "high",
      "reason": "This setup combines a high squeeze potential (30.6% short interest, 9.8 days to cover) with a hard, impending catalyst: the April 20 spin-off of First Tracks Biotherapeutics. With the corporate action just 5 days away, shorts are heavily incentivized to cover to avoid corporate action liabilities, supported by a fresh MACD bullish crossover with a positive 0.816 histogram. The options flow further corroborates the bullish setup with a low 0.41 put/call volume ratio against a strong technical uptrend. However, the thesis carries risk due to recent insider selling of approximately $2.2M by the CEO and Director, alongside a high ATR of 6.0% demanding careful position sizing.",
      "description": "AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States."
    },
    {
      "rank": 3,
      "ticker": "EQR",
      "company_name": "Equity Residential",
      "current_price": 61.290000915527344,
      "strategy_match": "volume_divergence",
      "final_score": 75,
      "confidence": 7,
      "risk_level": "low",
      "reason": "The stock presents a robust quantitative volume divergence signal, with OBV running +22.1% above average volume while the price remained flat (+1.8%), indicating covert multi-week institutional accumulation. Technical indicators are aligning favorably right now, characterized by a fresh MACD bullish crossover and the price holding firmly above its 20-day EMA and VWAP. Unusually high volume on deep ITM options, specifically 751 volume on $50 strike calls against an OI of just 2, alongside a low volatility profile (ATR 1.9%) offers an attractive low-risk entry. As a REIT, the primary risk is macroeconomic interest rate sensitivity which could unexpectedly compress valuation multiples despite the technical breakout.",
      "description": "Equity Residential owns and manages 312 rental properties consisting of 85,190 apartment units primarily in major U.S. coastal and high-growth metro areas."
    }
  ],
  "status": "ranked"
}